AMD outlined its next steps in the AI and HPC accelerator market at its 2025 Financial Analyst Day, revealing the Instinct MI400 series based on the CDNA 5 architecture. Scheduled for release in 2026, ...

The human biology major will provide students with a broad biological understanding of our species, from molecules, genes, and cells to tissues, organ systems and organism/environment interactions.

CareDx CDNA shares soared 7% in the last trading session to close at $12.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

CareDx has a unique, comprehensive organ transplant diagnostics portfolio and maintains strong revenue growth, but faces intensifying competition and regulatory risks. Recent legal resolutions and ...

CareDx (CDNA) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.03 per share a year ago. These figures are ...

CareDx Inc (NASDAQ:CDNA) reported a 32% year-over-year increase in quarterly revenue, reaching $86.6 million. The company achieved $9.8 million in adjusted EBITA in the fourth quarter and $27.8 ...

CareDx (CDNA) closed the last trading session at $23.10, gaining 1.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...

In addition to the Instinct MI325X AI Accelerator, AMD also updated its AMD Instinct roadmap and previewed the upcoming Instinct MI355X AI Accelerator at its Advance AI event held earlier. Based on ...

CDNA has resolved corporate instability and insurance issues, showing potential for sustainable growth with innovative transplant testing services like AlloSure, AlloMap, and HeartCare. CDNA's ...

AMD has revealed plans to integrate its current RDNA and CDNA architectures into a unified system called UDNA. This move is part of the company's broader strategy to strengthen its position in the ...